Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2018	Jun. 30, 2017
Current assets:
Cash	$ 40,403	$ 72,932
Prepaid expenses	4,105	6,426
Deposits and other receivables	1,000	1,980
Total current assets	45,508	81,338
Property and equipment, net (Note 3)	1,884	3,192
Total assets	47,392	84,530
Current liabilities:
Accounts payable and accrued expenses	946,590	865,841
Loans payable - affiliates (Note 4)	18,000
Deferred compensation (Note 5)	345,929	2,107,262
Convertible notes payable - affiliates (Note 7)		88,927
Loan payable and accrued interest (Note 6)	8,970,818	8,796,322
Total current liabilities	10,312,237	11,887,752
Convertible notes payable - affiliates (Note 7)	3,498,901	3,316,060
Total liabilities	13,811,138	15,203,812
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 25,327,394 and 24,748,213 shares issued, respectively; 24,623,085 and 24,043,904 shares outstanding, respectively
Additional paid-in capital	107,801,537	103,540,352
Subscription receivable - affiliates (Note 8)	(174,650)	(40,000)
Accumulated deficit	(121,445,479)	(118,676,966)
Total Bion's stockholders’ deficit	(13,818,592)	(15,176,614)
Noncontrolling interest	54,846	57,332
Total deficit	(13,763,746)	(15,119,282)
Total liabilities and deficit	47,392	84,530
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $33,500 and $32,000, respectively (Note 8)	30,900	29,400
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock